Innovative health technologies such as emotional freedom techniques or other energy medicine interventions.
Health economics and market access research for medications, medical devices and health interventions. Therapeutic areas include oncology, cardiology, Alzheimer’s disease, infectious disease, wound care.
Concurrent economic evaluation within clinical trials including country-specific evaluations from multinational trials.
Modeling studies have used excel-based models with partitioned survival or Markov, including probabilistic sensitivity analyses. Model adaptations to Canada have been conducted for many indications.
Assessment of quality of life and health state utility, patient reported outcome plans for trial design, as well as web-based collection of data to allow utility estimation.
Patient surveys and chart reviews have been conducted in oncology (infection post chemotherapy, prophylaxis against infection post chemotherapy, myelodysplastic syndromes)